The NSN 6505-01-252-0802 part numbers such as 4389-53, NDC00047 0451 30, NDC00074-4389-53, NDC00228-3067-50, NDC00364-2201-05 manufactured by Abbott Laboratories Inc, Warner Lambert Ltd, Actavis Inc, Schein Henry Inc, Mylan Pharmaceuticals Inc are available in RFQ Experts’ inventory. An ASAP Semiconductor owned and operated website, RFQ Experts has over six billion parts in its inventory for NSN 6505-01-252-0802. ASAP is committed to streamlining the parts procurement process for our customers, making it easy for them to search through billions of parts to find exactly what they are looking for. We have dedicated account managers ready to solve procurement issues our clients face, whether it’s a need for obsolete parts, or an aircraft on ground situation. As an AS9120B, ISO 9001:2015, and FAA AC 0056B certified company, each and every part that we ship goes through numerous quality checks and inspections, to ensure that we sell only the highest-quality parts.
Alternative NSN: 6505-01-252-0802 |
Item Name: Clorazepate Dipotassium Tablets Usp |
NIIN: 012520802 |
NCB Code: USA (01) |
Manufacturers: Abbott Laboratories Inc, Warner Lambert Ltd, Actavis Inc, Schein Henry Inc, Mylan Pharmaceuticals Inc, Rugby Group Inc, Danbury Pharmacal Inc, Taro Pharmaceuticals Usa Inc |
Abbott Laboratories Inc | Warner Lambert Ltd | Actavis Inc |
Schein Henry Inc | Mylan Pharmaceuticals Inc | Rugby Group Inc |
Danbury Pharmacal Inc | Taro Pharmaceuticals Usa Inc |
Part No | NSN | Item Name | QTY | RFQ |
---|---|---|---|---|
4389-53 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00047 0451 30 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00074-4389-53 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00228-3067-50 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00364-2201-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00378-0030-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00536-4940-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00591-0363-05 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC51672-4042-02 | 6505-01-252-0802 | clorazepate dipotassium tablets usp | Avl | RFQ |
MRC | Criteria | Characteristic |
---|---|---|
AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
You Can Click Here to Get Quote For Your Required Aircraft Parts Within 15 Minutes.
Request for Quote